![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 11, 9370-9377, March 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
,
§,
, and
¶
From the Low-density lipoprotein receptor-related protein
(LRP) is an endocytic receptor that binds multiple distinct ligands,
including blood coagulation factor VIII (FVIII). FVIII is a
heterodimeric multidomain protein that consists of a heavy chain
(domains A1, a1, A2, a2, and B) and a light chain (domains a3, A3, C1,
and C2). Both chains contribute to high-affinity interaction with LRP.
One LRP-interactive region has previously been located in the C2
domain, but its affinity is low in comparison with that of the entire
FVIII light chain. We now have compared a variety of FVIII light chain
derivatives with the light chain of its homolog FVa for LRP binding. In
surface plasmon resonance studies employing LRP cluster II, the FVa and
FVIII light chains proved different in that only FVIII displayed
high-affinity binding. Because the FVIII a3-A3-C1 fragment was
effective in associating with LRP, this region was explored for
structural elements that are exposed but not conserved in FV.
Competition studies using synthetic peptides suggested that LRP binding
involves the FVIII-specific region Lys1804-Ala1834 in the A3 domain. In
line with this observation, LRP binding was inhibited by a recombinant
antibody fragment that specifically binds to the FVIII sequence
Glu1811-Lys1818. The role of this sequence in
LRP binding was further tested using a FVIII/FV chimera in which
sequence Glu1811-Lys1818 was replaced with the
corresponding sequence of FV. Although this chimera still displayed
residual binding to LRP cluster II, its affinity was reduced. This
suggests that multiple sites in FVIII contribute to high-affinity LRP
binding, one of which is the FVIII A3 domain region
Glu1811-Lys1818. This suggests that LRP
binding to the FVIII A3 domain involves the same structural elements
that also contribute to the assembly of FVIII with FIXa.
Department of Plasma Proteins, Sanquin
Research at CLB, 1066 CX Amsterdam, The Netherlands and the
¶ Department of Pharmaceutics, Utrecht Institute for
Pharmaceutical Sciences, Utrecht University,
3584 CA Utrecht, The Netherlands
To whom correspondence should be addressed: Dept. of Plasma
Proteins, Sanquin Research at CLB, Sanquin Blood Supply Foundation, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands. Tel.:
31-20-512-3120; Fax: 31-20-512-3680; E-mail:
k.mertens@sanquin.nl.
This article has been cited by other articles:
![]() |
B. W. Shen, P. C. Spiegel, C.-H. Chang, J.-W. Huh, J.-S. Lee, J. Kim, Y.-H. Kim, and B. L. Stoddard The tertiary structure and domain organization of coagulation factor VIII Blood, February 1, 2008; 111(3): 1240 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bovenschen, K. Mertens, L. Hu, L. M. Havekes, and B. J. M. van Vlijmen LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo Blood, August 1, 2005; 106(3): 906 - 912. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |